Clonazepam Orally Disintegrating Tablets, USP, 0.125 mg

Glenmark Pharmaceuticals Inc., USA has initiated a Class II recall for 96,948 packs of Ondansetron Orally Disintegrating Tablets, 4mg, due to defective, unsealed blister packs. This nationwide recall, stemming from a product manufactured in India, highlights critical supply chain vulnerabilities and quality control challenges for procurement and regulatory teams managing essential antiemetic supplies.

Endo USA, Inc. has initiated a voluntary Class I recall for 8,029 cartons of Clonazepam Orally Disintegrating Tablets, USP, 0.125 mg. This critical action stems from a labeling error where cartons displayed incorrect strength, posing significant patient safety risks. Procurement and regulatory teams must assess immediate supply chain disruptions and scrutinize quality control protocols for similar products.